These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 6373155)

  • 1. Indapamide versus beta-blocker therapy: a double-blind, crossover study in essential hypertension.
    Rumboldt Z; Rumboldt M; Jurisic M
    Curr Med Res Opin; 1984; 9(1):10-20. PubMed ID: 6373155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of once daily indapamide and pindolol on blood pressure, plasma aldosterone concentration and plasma renin activity in a general practice setting.
    Chalmers JP; Wing LM; Grygiel JJ; West MJ; Graham JR; Bune AJ
    Eur J Clin Pharmacol; 1982; 22(3):191-6. PubMed ID: 7049706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multicenter dose-response study of the effect of indapamide in the treatment of patients with mild to moderate hypertension.
    Capone P; Vukovich RA; Neiss ES; Bolton S; Reeves RL
    Clin Ther; 1983; 5(3):305-16. PubMed ID: 6342786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A crossover comparison of the antihypertensive effects of indapamide and pindolol].
    Rumboldt Z; Rumboldt M; Jurisić M
    Lijec Vjesn; 1983 Jun; 105(6):239-44. PubMed ID: 6355727
    [No Abstract]   [Full Text] [Related]  

  • 5. Double-blind comparison of indapamide with a placebo in hypertensive patients treated by practicing physicians.
    Schaller MD; Waeber B; Brunner HR
    Clin Exp Hypertens A; 1985; 7(7):985-94. PubMed ID: 3899418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Indapamide in the treatment of essential arterial hypertension: results of a controlled study.
    Plante GE; Robillard C
    Curr Med Res Opin; 1983; 8 Suppl 3():59-66. PubMed ID: 6352186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term efficacy of a new, fixed, very-low-dose angiotensin-converting enzyme-inhibitor/diuretic combination as first-line therapy in elderly hypertensive patients.
    Chalmers J; Castaigne A; Morgan T; Chastang C
    J Hypertens; 2000 Mar; 18(3):327-37. PubMed ID: 10726720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Indapamide SR versus candesartan and amlodipine in hypertension: the X-CELLENT Study.
    London G; Schmieder R; Calvo C; Asmar R
    Am J Hypertens; 2006 Jan; 19(1):113-21. PubMed ID: 16461202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Indapamide and atenolol in the treatment of hypertension: double-blind comparative and combination study.
    De Divitiis O; Di Somma S; Petitto M; Fazio S; Ligouri V
    Curr Med Res Opin; 1983; 8(7):493-500. PubMed ID: 6354604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative study on the antihypertensive efficacy of torasemide and indapamide in patients with essential hypertension.
    Spannbrucker N; Achhammer I; Metz P; Glocke M
    Arzneimittelforschung; 1988 Jan; 38(1A):190-3. PubMed ID: 3285833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of indapamide 1.25 mg once daily in elderly patients with mild to moderate hypertension.
    Fiddes R; Blumenthal J; Dawson JE; Dyckman E; St John Hammond PG; Harris S; Lasseter KC; Levine BS; Montoro R; Niederman AL; Ratner PH; Rosenblatt S; Toth PD; Vergis J; Codispoti J
    J Hum Hypertens; 1997 Apr; 11(4):239-44. PubMed ID: 9185029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of indapamide in the treatment of hypertension.
    Anavekar SN; Ludbrooke A; Louis WJ; Doyle AE
    J Cardiovasc Pharmacol; 1979; 1(4):389-94. PubMed ID: 94616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical evaluation of muzolimine and indapamide during treatment for essential hypertension.
    Kirsten R; Molz KH; Tzonev I; Nelson K
    Z Kardiol; 1985; 74 Suppl 2():66-72. PubMed ID: 4002807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-dose antihypertensive therapy with 1.5 mg sustained-release indapamide: results of randomised double-blind controlled studies. European study group.
    Ambrosioni E; Safar M; Degaute JP; Malin PL; MacMahon M; Pujol DR; de Cordoüe A; Guez D
    J Hypertens; 1998 Nov; 16(11):1677-84. PubMed ID: 9856369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical efficacy and safety of indapamide in essential hypertension.
    Morledge JH
    Am Heart J; 1983 Jul; 106(1 Pt 2):229-32. PubMed ID: 6346846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fixed low-dose combination therapy in hypertension--a dose response study of perindopril and indapamide.
    Myers MG; Asmar R; Leenen FH; Safar M
    J Hypertens; 2000 Mar; 18(3):317-25. PubMed ID: 10726719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Indapamide versus hydrochlorothiazide in essential hypertension: measurement of peripheral resistance using plethysmography.
    Ogilvie R; Langlois S; Kreeft J
    Curr Med Res Opin; 1983; 8 Suppl 3():67. PubMed ID: 6352187
    [No Abstract]   [Full Text] [Related]  

  • 18. Efficacious response with lower dose indapamide therapy in the treatment of elderly patients with mild to moderate hypertension.
    Weidler D; Jallad NS; Curry C; Ferdinand K; Jain AK; Schnaper HW; Toth PD; Codispoti J; Stokes A; McNally C
    J Clin Pharmacol; 1995 Jan; 35(1):45-51. PubMed ID: 7751412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparative study of the activity of a new agent, indapamide, in essential arterial hypertension.
    Hatt PY; Leblond JB
    Curr Med Res Opin; 1975; 3(3):138-44. PubMed ID: 1097194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Therapeutic benefit of a low dose of indapamide: results of a double-blind against placebo European controlled study].
    Asmar R; Guez D; Malbezin M; Brault Y; de Cordoue A; Barrandon S; Bruxelles MC; Chastang C
    Arch Mal Coeur Vaiss; 1995 Aug; 88(8):1083-7. PubMed ID: 8572850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.